复方苦参注射液可明显降低化疗药物的毒副反应，提高患者的生活质量。
Composite Sophorae Injection can reduce the toxicity and adverse effects caused by chemotherapy medicine, and improve quality of life.
分子靶向治疗比传统的化疗特异性强、毒副反应小，将成为今后肿瘤治疗的新趋势。
Molecular targeted therapy has limited or nonexistent side effects on normal cells of the body, unlike traditional chemotherapy.
主要毒副反应为骨髓抑制和静脉炎。
主要的毒副反应为血液毒性。
肺腺癌；易瑞沙；毒副反应；治疗结果。
Lung neoplasm; Iressa; Toxicity reaction; Treatment outcome.
此局部治疗耐受性好，无明显毒副反应。
This local regimen was well tolerated without any undesired side effects.
骨髓抑制是主要的毒副反应，这一点早有报道。
Myelosuppression was the major toxicity, as has been reported previously with this regimen.
观察拓朴替康治疗小细胞肺癌的疗效和毒副反应。
To observe the effect and toxicity of topotecan in the treatment for small cell lung cancer(SCLC).
毒副反应均可耐受，主要是骨髓抑制和输液相关的不良反应。
The major toxic effects were bone marrow suppression and infusion related reaction that all patients could tolerate.
目的探讨低剂量健择增敏放射治疗胰腺癌的疗效及毒副反应。
Objective to study the effects of the low-dose gemcitabine sensitizing radiotherapy to the Pancreatic cancer as well as its toxic side effects.
结果44例患者能积极配合治疗，治疗的毒副反应低，疗效好。
Results: 44 patients could cooperate during treatment and had low tox-side reaction but good therapeutic effect.
观察两组患者毒副反应发生率、消化道反应以及生活质量情况。
Incidence of toxic and adverse reaction, digestive tract reaction and quality of life in patients of two groups were observed.
主要毒副反应为骨髓抑制、胃肠道反应、周围神经毒性及静脉炎。
The main side effects were myelosuppresion, gastrointestinal reation and peripheral nerve toxicity and phlebitis.
目的观察紫杉醇联合顺铂治疗晚期头颈部肿瘤的疗效及毒副反应。
Objective to study the efficacy and toxicities of paclitaxel combined with cisplatin in the treatment of patients with advanced head and neck neoplasms.
目的观察紫杉醇联合顺铂治疗晚期非小细胞肺癌近期疗效及毒副反应。
Objective to evaluate the recent period efficacy and toxicity reactions of paclitaxel plus cisplatin in the treatment of advanced non-small cell lung cancer.
目的观察腹腔化疗联合静脉化疗治疗晚期胃癌的临床疗效及毒副反应。
Objective to observe the therapeutic efficacy and side effects of intraperitoneal chemotherapy combined with intravenous chemotherapy.
目的观察伊立替康联合奈达铂二线治疗小细胞肺癌的疗效及毒副反应。
Objective To evaluate the efficacy and toxicity of irinotecan combined with nedaplatin in second-line therapy of small-cell lung cancer.
目的观察紫杉醇联合顺铂治疗远处转移的晚期鼻咽癌的疗效和毒副反应。
Objective to observe the efficacy and toxicities of paclitaxel combined with DDP in treatment of advanced nasopharyngeal carcinoma.
目的：观察国产多烯紫杉醇联合顺铂治疗晚期乳腺癌的疗效及毒副反应。
Objective: to observe the effects and toxicity of docetaxel plus DDP in treatment of advanced breast cancer.
目的：综述雷公藤作为免疫抑制剂在临床上的毒副反应及临床减毒方法。
Objective: to review Tripterygium Wifordii as immunosuppressant in the clinical toxicity and clinical attenuated method.
目的探讨榄香烯乳联合化疗药物在肝癌介入治疗中的临床疗效和毒副反应。
Objective To Study the therapeutic effect and side-effect of transcatheter arterial infusion chemotherapy(TAI)combined with element emulsion for primary hepatic carcinoma.
结论平消胶囊可以配合化疗治疗消化系恶性肿瘤，提高疗效，减轻毒副反应。
Conclusion Pingxiao Capsule can be combined with chemotherapy in the treatment of malignant tumors in digestive system, improve efficacy, reduce the toxicity.
目的：观察美能注射液联合化疗治疗中晚期妇科恶性肿瘤的疗效和毒副反应。
OBJECTIVE: To observe the efficacy and toxic reactions of strong neominophagen C injection in combination with chemotherapy in the treatment of intermediate and end-stage gynecological tumors.
结论改良的FOLFOX 4方案治疗晚期大肠癌疗效较高，毒副反应可耐受。
Conclusions The modified FOLFOX4 regimen is highly effective and well tolerated in treatment of advanced colorectal cancer.
目的观察比较FOLFOX方案与TCF方案治疗晚期胃癌的疗效、毒副反应。
Objective to compare the effect and toxicity between FOLFOX regimen and TCF regimen in patients with advanced gastric cancer.
目的观察苦参注射液加化疗与单纯化疗对晚期非小细胞肺癌的疗效及毒副反应。
Objective To compare the efficacy and side-effect of Kushen injection combined with chemotherapy and chemotherapy alone in the treatment of non-small cell lung cancer (NSCLC).
因此，5-FU血药浓度监测和毒副反应严重程度的预测具有重要的临床意义。
So monitoring serum concentration and predicting toxicity of 5-FU mean clinical sense.
毒副反应主要为消化道反应、脱发、骨髓抑制及发热，均属轻度或可逆性反应。
The major toxic side effects were gastrointestinal tract reaction, alopecia, myelosuppession and fever, but most of them were mild and reversible.
目的：研究表柔比星加紫杉醇新辅助化疗方案治疗乳腺癌的近期疗效及毒副反应。
Purpose: To study the short-term efficacy and toxicity of the neoajuvant chemotherapy with epirubicin (EPI) plus paclitaxel( TAX) in treatment of patients with breast cancer.
目的观察以紫杉类为主的联合化疗方案治疗晚期恶性肿瘤的临床疗效及毒副反应。
Objective To evaluate the efficiency and toxicity of paclitaxel in patients with advanced malignancies.
应用推荐